NBIX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $74,342,552.46

Neurocrine Biosciences Insider Trading History Chart

Neurocrine Biosciences Share Price & Price History

^$146.23

▼ -5.6 (-3.69%)

As of 09/18/2026 04:00 PM ET

Days: 30 | 90 | 365

Neurocrine Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/14/2026	David W. Boyer	Insider	Sell	826	$157.45	$130,053.70	8,722
9/14/2026	Matt Abernethy	CFO	Sell	2,311	$157.20	$363,289.20	42,808
7/28/2026	Leslie V Norwalk	Director	Sell	1,250	$182.01	$227,512.50	1,588
7/10/2026	Ingrid Delaet	Insider	Sell	4,367	$181.02	$790,514.34	16,225
7/9/2026	Darin Lippoldt	Insider	Sell	10,000	$179.60	$1,796,000.00	54,729
7/9/2026	Ingrid Delaet	Insider	Sell	8,433	$178.72	$1,507,145.76	16,225
7/8/2026	Ingrid Delaet	Insider	Sell	2,737	$178.54	$488,663.98	16,225
7/7/2026	Ingrid Delaet	Insider	Sell	3,401	$178.57	$607,316.57	16,225
6/29/2026	Darin Lippoldt	Insider	Sell	9,800	$170.16	$1,667,568.00	54,729
6/26/2026	Darin Lippoldt	Insider	Sell	200	$169.56	$33,912.00	54,729
6/5/2026	Stephen A. Sherwin	Director	Sell	25,000	$165.32	$4,133,000.00	15,860
6/4/2026	Leslie V Norwalk	Director	Sell	1,250	$168.06	$210,075.00	2,838
6/2/2026	Julie Cooke	Insider	Sell	36,937	$156.22	$5,770,298.14	22,374
6/1/2026	Jude Onyia	Insider	Sell	11,000	$160.25	$1,762,750.00	25,846
5/29/2026	Ingrid Delaet	Insider	Sell	2,261	$156.71	$354,321.31	16,225
5/27/2026	Jude Onyia	Insider	Sell	11,000	$155.53	$1,710,830.00	25,846
5/26/2026	David W. Boyer	Insider	Sell	3,888	$156.64	$609,016.32	7,799
5/19/2026	Kevin Charles Gorman	Director	Sell	245,088	$154.33	$37,824,431.04	511,293
5/15/2026	Richard F. Pops	Director	Sell	15,000	$157.65	$2,364,750.00	34,480
5/12/2026	Leslie V Norwalk	Director	Sell	3,810	$155.01	$590,588.10	2,429
1/16/2026	Kyle Gano	CEO	Sell	36,400	$132.70	$4,830,280.00	140,407
12/16/2025	Leslie V Norwalk	Director	Sell	1,190	$155.09	$184,557.10	6,239
12/15/2025	Leslie V Norwalk	Director	Sell	5,000	$152.23	$761,150.00	7,429
12/8/2025	Darin Lippoldt	Insider	Sell	4,376	$159.65	$698,628.40	43,405
11/25/2025	George J Morrow	Director	Sell	15,000	$143.37	$2,150,550.00	7,068
11/5/2025	William H. Rastetter	Director	Sell	18,000	$151.82	$2,732,760.00	40,360
11/4/2025	Kyle Gano	CEO	Sell	300	$141.97	$42,591.00	140,407
8/7/2025	Kevin Charles Gorman	Director	Sell	106,322	$126.41	$13,440,164.02	514,596
7/10/2025	Ingrid Delaet	Insider	Sell	457	$135.00	$61,695.00	4,730
7/9/2025	Jude Onyia	Insider	Sell	59,819	$130.46	$7,803,986.74	18,289
7/2/2025	Jude Onyia	Insider	Sell	20,362	$130.13	$2,649,707.06	18,289
5/27/2025	Kevin Charles Gorman	Director	Sell	9,613	$120.38	$1,157,212.94	514,596
5/5/2025	William H. Rastetter	Director	Sell	30,000	$110.20	$3,306,000.00	37,491
2/13/2025	Julie Cooke	Insider	Sell	1,551	$116.78	$181,125.78	19,544
2/13/2025	Kevin Charles Gorman	Director	Sell	5,844	$116.69	$681,936.36	521,618
2/13/2025	Matt Abernethy	CFO	Sell	2,558	$116.86	$298,927.88	34,775
2/10/2025	Julie Cooke	Insider	Sell	700	$118.28	$82,796.00	18,831
2/10/2025	Kevin Charles Gorman	Director	Sell	2,274	$118.37	$269,173.38	519,074
2/10/2025	Kyle Gano	CEO	Sell	980	$118.39	$116,022.20	137,658
2/3/2025	Ingrid Delaet	Insider	Sell	623	$149.29	$93,007.67	3,442
1/31/2025	Julie Cooke	Insider	Sell	1,740	$152.89	$266,028.60	18,202
1/31/2025	Kevin Charles Gorman	Director	Sell	2,707	$152.92	$413,954.44	517,030
1/31/2025	Kyle Gano	CEO	Sell	1,541	$152.87	$235,572.67	136,778
1/31/2025	Matt Abernethy	CFO	Sell	1,283	$152.87	$196,132.21	32,681
1/27/2025	Kevin Charles Gorman	Director	Sell	146,105	$149.46	$21,836,853.30	514,596
1/15/2025	Kyle Gano	CEO	Sell	65,000	$141.50	$9,197,500.00	135,392
12/31/2024	Ingrid Delaet	Insider	Sell	272	$138.10	$37,563.20	2,507
12/17/2024	Ingrid Delaet	Insider	Sell	1,091	$135.00	$147,285.00	2,507
11/29/2024	Jude Onyia	Insider	Sell	2,331	$126.29	$294,381.99	15,449
8/15/2024	William H. Rastetter	Director	Sell	14,250	$146.69	$2,090,332.50	37,491
8/13/2024	Gary A. Lyons	Director	Sell	11,570	$150.43	$1,740,475.10	119,047
8/13/2024	Ingrid Delaet	Insider	Sell	7,143	$150.10	$1,072,164.30	2,507
8/13/2024	Matt Abernethy	CFO	Sell	14,100	$150.38	$2,120,358.00	31,528
8/6/2024	Ingrid Delaet	Insider	Sell	273	$147.70	$40,322.10	6,607
8/1/2024	Julie Cooke	Insider	Sell	12,632	$153.26	$1,935,980.32	18,202
7/16/2024	Gary A. Lyons	Director	Sell	930	$150.03	$139,527.90	119,047
7/16/2024	Julie Cooke	Insider	Sell	900	$150.04	$135,036.00	18,202
7/1/2024	Julie Cooke	Insider	Sell	10,000	$140.19	$1,401,900.00	18,202
5/29/2024	Stephen A. Sherwin	Director	Sell	40,000	$133.46	$5,338,400.00	26,504
5/17/2024	Shalini Sharp	Director	Sell	1,106	$141.90	$156,941.40	994
5/15/2024	Matt Abernethy	CFO	Sell	15,000	$140.24	$2,103,600.00	31,528
5/14/2024	Gary A. Lyons	Director	Sell	12,500	$135.63	$1,695,375.00	116,947
5/6/2024	Ingrid Delaet	Insider	Sell	273	$140.55	$38,370.15	7,507
4/15/2024	Eric Benevich	Insider	Sell	19,818	$133.36	$2,642,928.48	40,778
3/21/2024	Ingrid Delaet	Insider	Sell	5,000	$145.06	$725,300.00	7,507
3/14/2024	Eric Benevich	Insider	Sell	75,000	$139.38	$10,453,500.00	40,778
3/14/2024	George J. Morrow	Director	Sell	40,000	$139.42	$5,576,800.00
3/11/2024	Ingrid Delaet	Insider	Sell	200	$140.00	$28,000.00	7,507
3/11/2024	Richard F. Pops	Director	Sell	100	$140.00	$14,000.00	29,512
3/8/2024	Ingrid Delaet	Insider	Sell	1,800	$140.03	$252,054.00	7,507
3/8/2024	Richard F. Pops	Director	Sell	1,700	$140.05	$238,085.00	29,512
2/29/2024	Ingrid Delaet	Insider	Sell	273	$135.51	$36,994.23	7,507
2/27/2024	Leslie V. Norwalk	Director	Sell	8,000	$135.67	$1,085,360.00
2/20/2024	Richard F. Pops	Director	Sell	15,000	$132.47	$1,987,050.00	29,512
2/13/2024	Eiry Roberts	Insider	Sell	1,114	$132.96	$148,117.44	23,716
2/13/2024	Kevin Charles Gorman	CEO	Sell	2,832	$133.02	$376,712.64	514,596
2/13/2024	Matt Abernethy	CFO	Sell	1,352	$132.85	$179,613.20	31,528
2/8/2024	David W. Boyer	Insider	Sell	1,328	$135.41	$179,824.48	4,895
2/8/2024	Kevin Charles Gorman	CEO	Sell	2,274	$134.15	$305,057.10	506,962
2/8/2024	Matt Abernethy	CFO	Sell	980	$134.21	$131,525.80	30,314
2/6/2024	David W. Boyer	Insider	Sell	456	$141.96	$64,733.76	4,894
2/6/2024	Kevin Charles Gorman	CEO	Sell	3,040	$142.18	$432,227.20	504,919
2/6/2024	Matt Abernethy	CFO	Sell	1,280	$142.19	$182,003.20	29,434
1/31/2024	Eiry Roberts	Insider	Sell	1,457	$140.79	$205,131.03	20,832
1/31/2024	Kevin Charles Gorman	CEO	Sell	2,707	$140.69	$380,847.83	502,188
1/31/2024	Matt Abernethy	CFO	Sell	1,283	$140.72	$180,543.76	28,284
1/22/2024	Darin Lippoldt	Insider	Sell	10,000	$139.86	$1,398,600.00	35,882
1/8/2024	Kevin Charles Gorman	CEO	Sell	105,835	$132.44	$14,016,787.40	499,754
1/2/2024	Kyle Gano	Insider	Sell	75,000	$131.47	$9,860,250.00	130,250
1/2/2024	William H. Rastetter	Director	Sell	11,044	$131.47	$1,451,954.68	51,741
12/22/2023	Eiry Roberts	Insider	Sell	10,000	$126.74	$1,267,400.00	19,521
12/12/2023	Eiry Roberts	Insider	Sell	13,925	$120.30	$1,675,177.50	29,521
12/8/2023	Eiry Roberts	Insider	Sell	300	$120.10	$36,030.00	29,521
12/6/2023	Darin Lippoldt	Insider	Sell	20,830	$119.86	$2,496,683.80	35,882
12/1/2023	Gary A. Lyons	Director	Sell	5,000	$116.77	$583,850.00	203,697
11/29/2023	Jude Onyia	Insider	Sell	2,331	$113.57	$264,731.67	11,732
11/27/2023	Darin Lippoldt	Insider	Sell	10,919	$112.27	$1,225,876.13	35,882
10/2/2023	David W. Boyer	Insider	Sell	1,437	$112.68	$161,921.16	4,894

SEC Filings (Institutional Ownership Changes) for Neurocrine Biosciences (NASDAQ:NBIX)

92.59% of Neurocrine Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Neurocrine Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/11/2026	Talon Private Wealth LLC	4,662	$0.79M	0.1%	-2.7%	0.005%
9/9/2026	Sequoia Financial Advisors LLC	6,351	$1.07M	0.0%	+31.0%	0.006%
9/9/2026	Tidal Investments LLC	81,460	$13.73M	0.0%	+186.7%	0.080%
9/9/2026	National Pension Service	16,310	$2.75M	0.0%	-48.0%	0.016%
9/9/2026	WINTON GROUP Ltd	1,600	$0.27M	0.0%	N/A	0.002%
9/9/2026	Engineers Gate Manager LP	18,361	$3.09M	0.0%	+64.0%	0.018%
9/9/2026	Integrated Wealth Concepts LLC	8,041	$1.36M	0.0%	-41.5%	0.008%
9/9/2026	RFG Advisory LLC	8,195	$1.38M	0.0%	N/A	0.008%
9/9/2026	NewEdge Advisors LLC	12,619	$2.13M	0.0%	-3.4%	0.012%
9/9/2026	IFP Advisors Inc	3,008	$0.51M	0.0%	+7.7%	0.003%
9/9/2026	Squarepoint Ops LLC	44,143	$7.44M	0.0%	-91.0%	0.043%
9/9/2026	Baird Financial Group Inc.	39,868	$6.72M	0.0%	+3.3%	0.039%
9/8/2026	Allworth Financial LP	14,853	$2.50M	0.0%	+74.6%	0.015%
9/8/2026	Arizona State Retirement System	27,337	$4.61M	0.0%	+0.9%	0.027%
9/8/2026	West Family Investments Inc.	1,923	$0.32M	0.1%	N/A	0.002%
9/8/2026	Carmignac Gestion	214,100	$36.08M	0.5%	+15.1%	0.211%
9/8/2026	Nykredit A S	30,811	$5.19M	0.0%	N/A	0.030%
9/2/2026	Range Advisory LLC	2,237	$0.38M	0.0%	N/A	0.002%
8/27/2026	Corient Private Wealth LP	54,680	$9.22M	0.0%	+21.4%	0.054%
8/26/2026	Amundi	220,463	$37.16M	0.0%	+8.3%	0.217%
8/26/2026	HighTower Advisors LLC	8,205	$1.38M	0.0%	-26.7%	0.008%
8/25/2026	VIRGINIA RETIREMENT SYSTEMS ET Al	245,923	$41.45M	0.2%	N/A	0.242%
8/23/2026	Nilsine Partners LLC	10,013	$1.69M	0.1%	+3.6%	0.010%
8/23/2026	Saudi Central Bank	6,674	$1.13M	0.0%	+81.4%	0.007%
8/23/2026	Azimuth Capital Investment Management LLC	112,466	$18.95M	0.6%	-7.6%	0.111%
8/22/2026	BAM Wealth Management LLC	2,598	$0.44M	0.3%	+8.9%	0.003%
8/22/2026	denkapparat Operations GmbH	7,188	$1.21M	0.4%	+23.6%	0.007%
8/21/2026	Braidwell LP	336,171	$56.66M	2.1%	-48.4%	0.331%
8/21/2026	Continuum Advisory LLC	418	$70K	0.0%	-99.1%	0.000%
8/21/2026	Nykredit A S	37,372	$6.30M	0.0%	N/A	0.037%
8/21/2026	Legacy Financial Advisors Inc.	1,246	$0.21M	0.0%	-34.3%	0.001%
8/20/2026	Rehmann Capital Advisory Group	8,460	$1.43M	0.1%	N/A	0.008%
8/20/2026	Susquehanna Fundamental Investments LLC	1,422	$0.24M	0.0%	N/A	0.001%
8/20/2026	Sigma Planning Corp	10,008	$1.69M	0.0%	N/A	0.010%
8/20/2026	Harvest Management LLC	1,617	$0.27M	0.1%	N/A	0.002%
8/20/2026	Northwestern Mutual Wealth Management Co.	900	$0.15M	0.0%	+254.3%	0.001%
8/20/2026	Meiji Yasuda Life Insurance Co	5,628	$0.95M	0.0%	+1.8%	0.006%
8/20/2026	Penn Capital Management Company LLC	10,600	$1.81M	0.1%	N/A	0.010%
8/20/2026	Greenleaf Trust	1,993	$0.34M	0.0%	N/A	0.002%
8/19/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	504,233	$84.98M	0.0%	-11.8%	0.496%
8/19/2026	Van ECK Associates Corp	69,482	$11.71M	0.0%	-22.0%	0.068%
8/19/2026	Nissay Asset Management Corp Japan	12,463	$2.10M	0.0%	-1.0%	0.012%
8/19/2026	Hsbc Holdings PLC	115,990	$19.58M	0.0%	-37.0%	0.114%
8/19/2026	Wellington Management Group LLP	34,641	$5.84M	0.0%	-97.5%	0.034%
8/18/2026	Livforsakringsbolaget Skandia Omsesidigt	18,500	$3.12M	0.1%	N/A	0.018%
8/18/2026	Palo Alto Investors LP	18,117	$3.05M	0.0%	N/A	0.018%
8/18/2026	Empowered Funds LLC	13,827	$2.33M	0.0%	N/A	0.014%
8/18/2026	United Capital Financial Advisors LLC	1,539	$0.26M	0.0%	N/A	0.002%
8/18/2026	Jefferies Financial Group Inc.	10,630	$1.79M	0.0%	N/A	0.010%
8/18/2026	Public Employees Retirement System of Ohio	28,709	$4.84M	0.0%	N/A	0.028%
8/17/2026	Pure Financial Advisors LLC	1,662	$0.28M	0.0%	N/A	0.002%
8/17/2026	Transamerica Financial Advisors LLC	283	$48K	0.0%	N/A	0.000%
8/17/2026	Corient Private Wealth LP	46,762	$7.88M	0.0%	N/A	0.046%
8/17/2026	Bank of America Corp DE	619,352	$104.38M	0.0%	N/A	0.609%
8/15/2026	Caisse de depot et placement du Quebec	539,961	$91M	0.1%	N/A	0.531%
8/15/2026	Man Group plc	601,019	$101.29M	0.2%	N/A	0.591%
8/15/2026	Roberts Glore & Co. Inc. IL	1,317	$0.22M	0.1%	N/A	0.001%
8/15/2026	Jupiter Topco LLC	526,341	$88.71M	0.0%	N/A	0.518%
8/14/2026	Hsbc Holdings PLC	115,990	$19.58M	0.0%	N/A	0.114%
8/14/2026	Primecap Management Co. CA	491,340	$82.81M	0.0%	N/A	0.483%
8/14/2026	Canada Pension Plan Investment Board	81,700	$13.77M	0.0%	N/A	0.080%
8/14/2026	Legal & General Group Plc	314,451	$53M	0.0%	N/A	0.309%
8/14/2026	The Manufacturers Life Insurance Company	63,784	$10.75M	0.0%	N/A	0.063%
8/14/2026	Cetera Trust Company N.A	2,505	$0.42M	0.2%	N/A	0.002%
8/14/2026	Whalen Wealth Management Inc.	6,163	$1.04M	0.5%	N/A	0.006%
8/13/2026	Cibc World Market Inc.	3,258	$0.55M	0.0%	N/A	0.003%
8/13/2026	OMERS ADMINISTRATION Corp	5,210	$0.88M	0.0%	N/A	0.005%
8/13/2026	Sanctuary Advisors LLC	18,927	$3.19M	0.0%	N/A	0.019%
8/13/2026	Capital Square LLC	1,270	$0.23M	0.1%	N/A	0.001%
8/13/2026	Meiji Yasuda Asset Management Co Ltd.	5,312	$0.90M	0.0%	N/A	0.005%
8/13/2026	Globeflex Capital L P	28,363	$4.78M	0.6%	N/A	0.028%
8/13/2026	Bank of Nova Scotia	5,822	$0.98M	0.0%	N/A	0.006%
8/12/2026	Daiichi Life Insurance Co. Ltd.	14,741	$2.48M	0.1%	N/A	0.015%
8/12/2026	Commerce Bank	13,249	$2.23M	0.0%	N/A	0.013%
8/12/2026	Northwestern Mutual Wealth Management Co.	900	$0.15M	0.0%	N/A	0.001%
8/12/2026	Evolve Private Wealth LLC	5,036	$0.85M	0.1%	N/A	0.005%
8/12/2026	Landscape Capital Management L.L.C.	9,616	$1.62M	0.1%	N/A	0.009%
8/12/2026	Korea Investment CORP	172,989	$29.16M	0.1%	N/A	0.170%
8/12/2026	EP Wealth Advisors LLC	2,749	$0.46M	0.0%	N/A	0.003%
8/12/2026	Ieq Capital LLC	640,304	$107.91M	0.5%	N/A	0.630%
8/12/2026	Robinhood Asset Management LLC	60,484	$10.19M	0.5%	N/A	0.060%
8/12/2026	Callan Family Office LLC	2,824	$0.48M	0.0%	N/A	0.003%
8/12/2026	Expressive Wealth LLC	1,416	$0.24M	0.2%	N/A	0.001%
8/12/2026	C M Bidwell & Associates Ltd.	1,369	$0.23M	0.1%	N/A	0.001%
8/11/2026	Allworth Financial LP	14,853	$2.50M	0.0%	N/A	0.015%
8/11/2026	B. Metzler seel. Sohn & Co. AG	5,986	$1.01M	0.0%	N/A	0.006%
8/11/2026	TrinityBridge Ltd	268	$45K	0.0%	N/A	0.000%
8/11/2026	Virtus Advisers LLC	2,714	$0.46M	0.2%	N/A	0.003%
8/11/2026	Silvant Capital Management LLC	20,706	$3.49M	0.1%	N/A	0.020%
8/11/2026	Advisors Preferred LLC	31,074	$5.42M	0.8%	N/A	0.031%
8/11/2026	Vise Technologies Inc.	3,360	$0.57M	0.0%	N/A	0.003%
8/11/2026	E Fund Management Co. Ltd.	2,572	$0.43M	0.0%	N/A	0.003%
8/11/2026	Aurora Investment Counsel	8,724	$1.47M	0.8%	N/A	0.009%
8/10/2026	West Family Investments Inc.	1,923	$0.32M	0.1%	N/A	0.002%
8/10/2026	Great Lakes Advisors LLC	4,983	$0.84M	0.0%	N/A	0.005%
8/10/2026	Danske Bank A S	52,095	$8.78M	0.0%	N/A	0.051%
8/10/2026	Diversify Advisory Services LLC	2,506	$0.44M	0.0%	N/A	0.002%
8/8/2026	Meeder Advisory Services Inc.	1,439	$0.24M	0.0%	N/A	0.001%
8/7/2026	Citizens Financial Group Inc. RI	4,249	$0.72M	0.0%	N/A	0.004%
8/7/2026	Grandfield & Dodd LLC	16,659	$2.81M	0.1%	N/A	0.016%

Data available starting January 2016

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids. Its product candidates in clinical development include valbenazine to treat dyskinetic cerebral palsy in pediatrics and adults; NBI-921352 to treat developmental and epileptic encephalopathy syndrome in pediatrics and adults; NBI-827104 to treat epileptic encephalopathy with continuous spike-and-wave during sleep; NBI-1076986 to treat movement disorders; crinecerfront to treat congenital adrenal hyperplasia in adults and children; EFMODY to treat congenital adrenal hyperplasia and adrenal insufficiency in adults; valbenazine for the adjunctive treatment of schizophrenia; NBI-1065845 for the treatment of inadequate response to treatment in major depressive disorder; luvadaxistat to treat cognitive impairment related to schizophrenia; NBI-1117568 for the treatment of schizophrenia; NBI-1070770 to treat major depressive disorder; NBI-1117570 for the treatment of symptoms of psychosis and cognition in neurological and neuropsychiatric conditions; and NBI-1117569, NBI-1117567, and NBI-1065890 to treat CNS indications. The company also has license and collaboration agreements with Heptares Therapeutics Limited; Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Today's Range

Now: $146.23

$146.06

$152.63

50 Day Range

MA: $161.81

$146.23

$185.50

52 Week Range

Now: $146.23

$122.14

$186.12

Volume

2,815,385 shs

Average Volume

972,936 shs

Market Capitalization

$14.86 billion

P/E Ratio

21.44

Dividend Yield

N/A

Beta

0.38

Who are the company insiders with the largest holdings of Neurocrine Biosciences?: Neurocrine Biosciences' top insider shareholders include:
Neurocrine Biosciences Inc (Major Shareholder)
Kevin Charles Gorman (CEO)
Kevin Charles Gorman (Director)
Gary A Lyons (Director)
Gary A Lyons (Director)
Haig P Bozigian (Insider)
Darin Lippoldt (Insider)
Dimitri E Grigoriadis (Insider)
Kyle Gano (CEO)
Timothy P Coughlin (CFO)
Learn More about top insider investors at Neurocrine Biosciences.
Who are the major institutional investors of Neurocrine Biosciences?: Neurocrine Biosciences' top institutional investors include:
BlackRock Inc. — 13.49%
Bank of New York Mellon Corp — 0.69%
Ieq Capital LLC — 0.63%
Bank of America Corp DE — 0.61%
Man Group plc — 0.59%
Caisse de depot et placement du Quebec — 0.53%
Learn More about top institutional investors of Neurocrine Biosciences stock.
Which institutional investors are selling Neurocrine Biosciences stock?: During the previous quarter, NBIX stock was sold by these institutional investors:
Wellington Management Group LLP
Squarepoint Ops LLC
Braidwell LP
Hsbc Holdings PLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Continuum Advisory LLC
Van ECK Associates Corp
National Pension Service
During the previous year, company insiders that have sold Neurocrine Biosciences company stock include:
Kevin Charles Gorman (Director)
Kyle Gano (CEO)
Darin Lippoldt (Insider)
Matt Abernethy (CFO)
William H Rastetter (Director)
Richard F Pops (Director)
Jude Onyia (Insider)
Julie Cooke (Insider)
Ingrid Delaet (Insider)
Stephen A Sherwin (Director)
David W Boyer (Insider)
Leslie V Norwalk (Director)
George J Morrow (Director)
Learn More investors selling Neurocrine Biosciences stock.
Which institutional investors are buying Neurocrine Biosciences stock?: Within the previous quarter, NBIX stock was bought by institutional investors including:
BlackRock Inc.
Bank of New York Mellon Corp
Ieq Capital LLC
Bank of America Corp DE
Man Group plc
Caisse de depot et placement du Quebec
Jupiter Topco LLC
Primecap Management Co. CA